Dr. Staehler on novel PET imaging agent for kidney cancer

In this video, Michael Staehler, MD, a professor of Urology at the University of Munich, discusses early results with ⁶⁸GA-EMP-100 PET, a novel agent for imaging c-MET expression in renal cell carcinoma. Staehler presented that abstract, “First in-human results of ⁶⁸GA-EMP-100 PET for imaging c-MET expression in renal cell carcinoma,” at the 2022 AUA annual meeting (abstract PD18-11).